The file's text, extracted by GovTribe without its formatting.
B.4 Price/Cost Schedule:
Base Year Period of Performance: April 01, 2019 to March 31, 2020
| CLIN |
| CLIN Supplies |
| EST QTY |
| UNIT COST |
| TOTAL COST |
| 0001 |
| Sodium Pertechnetate Tc99M, U.D. |
| 20 |
| 0002 |
| Sodium Pertechnetate Tc99M per mCI |
| 865 |
| 0003 |
| Sodium Pertechnetate Tc99M Flood |
| 56 |
| 0007 |
| Sulfur Colloid Tc99M |
| 101 |
| 0008 |
| Sulfur Colloid Tc99M, Filtered |
| 17 |
| 0012 |
| Ceretec Tc99M WBC |
| 10 |
| 0013 |
| Co-57 Flood 15 mCi |
| 1 |
| 0014 |
| Cardiolote Tc99M |
| 4225 |
| 0015 |
| Thallous Chloride T1-201/mCi |
| 110 |
| 0016 |
| Sodium Iodide, 1-123, 200uCi |
| 50 |
| 0017 |
| Sodium Iodide, 1-131, 1 mCi |
| 10 |
| 0018 |
| Sodioum Iodide, I-131, 1 mCi, Each additional mCi |
| 575 |
| 0019 |
| Gallium Citrate GS-67/mCi |
| 5 |
| 0020 |
| Gallium Citrate, Ga-67 source |
| 1 |
| 0021 |
| In-111 Octreoscan |
| 10 |
| 0022 |
| Hepatolite-TC99m |
| 0-1 |
| 0023 |
| *Quadramet 153 Sa |
| 0-1 |
PET Radioisotopes:
| 0027 |
| F18-Vizamyl (dementia) |
| 0028 |
| Ga68-NETSPOT (neuroendocrine tumor) |
| 0029 |
| N13-Ammonia (cardiac) |
Non-radioactive products:
| 0031 |
| Venti-Scan IV & vent Kit |
| 42 |
| 0032 |
| Kinevac up to 0.8 micrograms (unit dose) |
| 75 |
| 0033 |
| Kinevac, Each additional 0.1 microgram |
| 875 |
ESTIMATED FOR BASE YEAR
OPTION YEAR ONE (1)
Option Year One Period of Performance: April 01, 2020 to March 31, 2021
| CLIN |
| CLIN Supplies |
| EST QTY |
| UNIT COST |
| TOTAL COST |
| 1001 |
| Sodium Pertechnetate Tc99M, U.D. |
| 20 |
| 1002 |
| Sodium Pertechnetate Tc99M per mCI |
| 865 |
| 1003 |
| Sodium Pertechnetate Tc99M Flood |
| 56 |
| 1007 |
| Sulfur Colloid Tc99M |
| 101 |
| 1008 |
| Sulfur Colloid Tc99M, Filtered |
| 17 |
| 1012 |
| Ceretec Tc99M WBC |
| 10 |
| 1013 |
| Co-57 Flood 15 mCi |
| 1 |
| 1014 |
| Cardiolote Tc99M |
| 4225 |
| 1015 |
| Thallous Chloride T1-201/mCi |
| 110 |
| 1016 |
| Sodium Iodide, 1-123, 200uCi |
| 50 |
| 1017 |
| Sodium Iodide, 1-131, 1 mCi |
| 10 |
| 1018 |
| Sodioum Iodide, I-131, 1 mCi, Each additional mCi |
| 575 |
| 1019 |
| Gallium Citrate GS-67/mCi |
| 5 |
| 1020 |
| Gallium Citrate, Ga-67 source |
| 1 |
| 1021 |
| In-111 Octreoscan |
| 10 |
| 1022 |
| Hepatolite-TC99m |
| 0-1 |
| 1023 |
| *Quadramet 153 Sa |
| 0-1 |
PET Radioisotopes:
| 1027 |
| F18-Vizamyl (dementia) |
| 1028 |
| Ga68-NETSPOT (neuroendocrine tumor) |
| 1029 |
| N13-Ammonia (cardiac) |
Non-radioactive products:
| 1031 |
| Venti-Scan IV & vent Kit |
| 42 |
| 1032 |
| Kinevac up to 0.8 micrograms (unit dose) |
| 75 |
| 1033 |
| Kinevac, Each additional 0.1 microgram |
| 875 |
ESTIMATED TOTAL OPTION YEAR 1
OPTION YEAR TWO (2)
Option Year Two Period of Performance: April 01, 2021 to March 31, 2022
| CLIN |
| CLIN Supplies |
| EST QTY |
| UNIT COST |
| TOTAL COST |
| 2001 |
| Sodium Pertechnetate Tc99M, U.D. |
| 20 |
| 2002 |
| Sodium Pertechnetate Tc99M per mCI |
| 865 |
| 2003 |
| Sodium Pertechnetate Tc99M Flood |
| 56 |
| 2007 |
| Sulfur Colloid Tc99M |
| 101 |
| 2008 |
| Sulfur Colloid Tc99M, Filtered |
| 17 |
| 2012 |
| Ceretec Tc99M WBC |
| 10 |
| 2013 |
| Co-57 Flood 15 mCi |
| 1 |
| 2014 |
| Cardiolote Tc99M |
| 4225 |
| 2015 |
| Thallous Chloride T1-201/mCi |
| 110 |
| 2016 |
| Sodium Iodide, 1-123, 200uCi |
| 50 |
| 2017 |
| Sodium Iodide, 1-131, 1 mCi |
| 10 |
| 2018 |
| Sodioum Iodide, I-131, 1 mCi, Each additional mCi |
| 575 |
| 2019 |
| Gallium Citrate GS-67/mCi |
| 5 |
| 2020 |
| Gallium Citrate, Ga-67 source |
| 1 |
| 2021 |
| In-111 Octreoscan |
| 10 |
| 2022 |
| Hepatolite-TC99m |
| 0-1 |
| 2023 |
| *Quadramet 153 Sa |
| 0-1 |
PET Radioisotopes:
| 2027 |
| F18-Vizamyl (dementia) |
| 2028 |
| Ga68-NETSPOT (neuroendocrine tumor) |
| 2029 |
| N13-Ammonia (cardiac) |
Non-radioactive products:
| 2031 |
| Venti-Scan IV & vent Kit |
| 42 |
| 2032 |
| Kinevac up to 0.8 micrograms (unit dose) |
| 75 |
| 2033 |
| Kinevac, Each additional 0.1 microgram |
| 875 |
ESTIMATED TOTAL OPTION YEAR 2
OPTION YEAR THREE (3)
Option Year Three Period of Performance: April 01, 2022 to March 31, 2023
| CLIN |
| CLIN Supplies |
| EST QTY |
| UNIT COST |
| TOTAL COST |
| 3001 |
| Sodium Pertechnetate Tc99M, U.D. |
| 20 |
| 3002 |
| Sodium Pertechnetate Tc99M per mCI |
| 865 |
| 3003 |
| Sodium Pertechnetate Tc99M Flood |
| 56 |
| 3007 |
| Sulfur Colloid Tc99M |
| 101 |
| 3008 |
| Sulfur Colloid Tc99M, Filtered |
| 17 |
| 3012 |
| Ceretec Tc99M WBC |
| 10 |
| 3013 |
| Co-57 Flood 15 mCi |
| 1 |
| 3014 |
| Cardiolote Tc99M |
| 4225 |
| 3015 |
| Thallous Chloride T1-201/mCi |
| 110 |
| 3016 |
| Sodium Iodide, 1-123, 200uCi |
| 50 |
| 3017 |
| Sodium Iodide, 1-131, 1 mCi |
| 10 |
| 3018 |
| Sodioum Iodide, I-131, 1 mCi, Each additional mCi |
| 575 |
| 3019 |
| Gallium Citrate GS-67/mCi |
| 5 |
| 3020 |
| Gallium Citrate, Ga-67 source |
| 1 |
| 3021 |
| In-111 Octreoscan |
| 10 |
| 3022 |
| Hepatolite-TC99m |
| 0-1 |
| 3023 |
| *Quadramet 153 Sa |
| 0-1 |
PET Radioisotopes:
| 3027 |
| F18-Vizamyl (dementia) |
| 3028 |
| Ga68-NETSPOT (neuroendocrine tumor) |
| 3029 |
| N13-Ammonia (cardiac) |
Non-radioactive products:
| 3031 |
| Venti-Scan IV & vent Kit |
| 42 |
| 3032 |
| Kinevac up to 0.8 micrograms (unit dose) |
| 75 |
| 3033 |
| Kinevac, Each additional 0.1 microgram |
| 875 |
ESTIMATED TOTAL OPTION YEAR 3
OPTION YEAR FOUR (4)
Option Year Four Period of Performance: April 01, 2023 to March 31, 2024
| CLIN |
| CLIN Supplies |
| EST QTY |
| UNIT COST |
| TOTAL COST |
| 4001 |
| Sodium Pertechnetate Tc99M, U.D. |
| 20 |
| 4002 |
| Sodium Pertechnetate Tc99M per mCI |
| 865 |
| 4003 |
| Sodium Pertechnetate Tc99M Flood |
| 56 |
| 4007 |
| Sulfur Colloid Tc99M |
| 101 |
| 4008 |
| Sulfur Colloid Tc99M, Filtered |
| 17 |
| 4012 |
| Ceretec Tc99M WBC |
| 10 |
| 4013 |
| Co-57 Flood 15 mCi |
| 1 |
| 4014 |
| Cardiolote Tc99M |
| 4225 |
| 4015 |
| Thallous Chloride T1-201/mCi |
| 110 |
| 4016 |
| Sodium Iodide, 1-123, 200uCi |
| 50 |
| 4017 |
| Sodium Iodide, 1-131, 1 mCi |
| 10 |
| 4018 |
| Sodioum Iodide, I-131, 1 mCi, Each additional mCi |
| 575 |
| 4019 |
| Gallium Citrate GS-67/mCi |
| 5 |
| 4020 |
| Gallium Citrate, Ga-67 source |
| 1 |
| 4021 |
| In-111 Octreoscan |
| 10 |
| 4022 |
| Hepatolite-TC99m |
| 0-1 |
| 4023 |
| *Quadramet 153 Sa |
| 0-1 |
PET Radioisotopes:
| 4027 |
| F18-Vizamyl (dementia) |
| 4028 |
| Ga68-NETSPOT (neuroendocrine tumor) |
| 4029 |
| N13-Ammonia (cardiac) |
Non-radioactive products:
| 4031 |
| Venti-Scan IV & vent Kit |
| 42 |
| 4032 |
| Kinevac up to 0.8 micrograms (unit dose) |
| 75 |
| 4033 |
| Kinevac, Each additional 0.1 microgram |
| 875 |
ESTIMATED TOTAL OPTION YEAR 4